Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about SRPT

Recent news which mentions SRPT

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
A Closer Look at 28 Analyst Recommendations For Sarepta Therapeutics
Tickers SRPT
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $600 Today
Tickers NEWS SRPT
Tags News BZI/POD Trading Ideas
From Benzinga
2 Biotech Stocks to Buy Hand Over Fist in August
Tickers SRPT VRTX
Tags Recent Press Releases Market News SRPT
From Motley Fool
Warner Bros, Airbnb And Monster Beverage Are Among Top 10 Large Cap Losers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
Tickers ABNB BLD CRL DELL
Tags DELL BLD Benzinga
From Benzinga
Smart Money Is Betting Big In SRPT Options
Tickers SRPT
Tags BZI/UOA Markets Benzinga
From Benzinga
McKesson Reports Weak Sales, Joins JFrog, Fastly, Warner Bros. Discovery And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Tickers BMBL BROS CDLX FROG
Tags Markets Benzinga SRPT
From Benzinga
7 Biotech Stocks to Buy for Their Game-Changing Potential
Tickers ALLO CRSP DTIL RGNX
Tags ALLO NASDAQ:ALLO,NASDAQ:CRSP,NASDAQ:DTIL,NASDAQ:RGNX,NASDAQ:SRPT,NASDAQ:VYGR Market News
From InvestorPlace
Sarepta Therapeutics (SRPT) Q2 2024 Earnings Call Transcript
Tickers SRPT
Tags Market News SRPT Recent Press Releases
From Motley Fool
SRPT Stock Earnings: Sarepta Therapeutics Beats EPS, Misses Revenue for Q2 2024
Tickers SRPT
Tags NASDAQ:SRPT Earnings Reports Market News
From InvestorPlace
3 Genomics Stocks That May Transform Personalized Medicine
Tickers RARE SRPT TECH
Tags RARE TECH Market News
From InvestorPlace
26 Analysts Have This To Say About Sarepta Therapeutics
Tickers SRPT
Tags BZI/AAR Benzinga SRPT
From Benzinga
Here's How Much $1000 Invested In Sarepta Therapeutics 10 Years Ago Would Be Worth Today
Tickers NEWS SRPT
Tags Trading Ideas News BZI/POD
From Benzinga
SAVA Stock Plunges as Cassava Sciences CEO Steps Down. What to Know.
Tickers SAVA SRPT
Tags SAVA SRPT Market News
From InvestorPlace
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
Tickers APD BJ COST FTNT
Tags News Jim Cramer PANW
From Benzinga
After a Big Win, Is Sarepta Therapeutics Stock a Buy?
Tickers SRPT
Tags SRPT Market News Recent Press Releases
From Motley Fool
Here's How Much $100 Invested In Sarepta Therapeutics 10 Years Ago Would Be Worth Today
Tickers NEWS SRPT
Tags BZI/POD News Trading Ideas
From Benzinga
Has Sarepta Therapeutics Become a No-Brainer Stock Buy After This Recent FDA News?
Tickers SRPT
Tags Market News SRPT Recent Press Releases
From Motley Fool
1 Soaring Growth Stock to Buy and Hold for 10 Years
Tickers SRPT
Tags SRPT Market News Recent Press Releases
From Motley Fool
Expert Outlook: Sarepta Therapeutics Through The Eyes Of 25 Analysts
Tickers SRPT
Tags Analyst Ratings Market News Benzinga
From Benzinga
Looking At Sarepta Therapeutics's Recent Unusual Options Activity
Tickers SRPT
Tags Market News Options Benzinga
From Benzinga
Is Pfizer's Pain Sarepta Therapeutics' Gain? Don't Bet on It.
Tickers PFE SRPT
Tags SRPT Market News PFE
From Motley Fool
Here's How Much You Would Have Made Owning Sarepta Therapeutics Stock In The Last 10 Years
Tickers NEWS SRPT
Tags Market News SRPT Benzinga
From Benzinga
Micron To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Monday
Tickers ARGX AVB HEI KMX
Tags Markets SRPT RCL
From Benzinga
DraftKings And Dell Were Among The 10 Biggest Large Cap Stock Gainers Last Week (June 16-June 22): Are These In Your Portfolio?
Tickers ACN ADSK CELH CHWY
Tags TOST ACN SIRI
From Benzinga
Growth Stocks Leave Value Stocks In The Dust: 4 Reasons For Biggest Monthly Lead In Over A Year
Tickers AAPL ADBE ADSK AMZN
Tags DXC IWD ETFs
From Benzinga
Nasdaq Moves Lower; FactSet Research Posts Upbeat Earnings
Tickers AREB CRKN FDS KAVL
Tags AREB Trading Ideas SWBI
From Benzinga
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Tickers AAGR ABL ADTN ALUR
Tags ADTN SMTK CDMO
From Benzinga
Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty
Tickers CTLT NEWS SRPT TMO
Tags Briefs TMO why it's moving
From Benzinga
Stocks Stall As Chip Sector Struggles To Rebound; Dollar Eyes 7-Week Peak, Gold, Bitcoin Retreat: What's Driving Markets Friday?
Tickers BITCOMP DIA ECON FDS
Tags Stories That Matter SPY Economics
From Benzinga
Sarepta's Expanded FDA Approval For Elevidys Potentially Shaping Future FDA Reviews, Analyst Says
Tickers NEWS SRPT
Tags Health Care News Analyst Color
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.